MAOB and Cognitive impairment: Superiority of the Triple-Acting 5-HT6R/5-HT3R Antagonist and MAO-B Reversible Inhibitor PZ-1922 over 5-HT6R Antagonist Intepirdine
in Alleviation of Cognitive Deficits in Rats